Alkeon Capital Management LLC Mersana Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.48 - $9.86 $9.86 Million - $17.7 Million	-1,799,838 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $55,032 - $93,027	-6,429 Reduced 0.36%	1,799,838 $17 Million
Q2 2021 Aug 16, 2021	SELL	$13.28 - $18.07 $56,280 - $76,580	-4,238 Reduced 0.23%	1,806,267 $24.5 Million
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $86,914 - $150,554	5,677 Added 0.31%	1,810,505 $29.3 Million
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $4.29 Million - $7.03 Million	254,828 Added 16.44%	1,804,828 $48 Million
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $25.1 Million - $39.8 Million	1,550,000 New	1,550,000 $28.9 Million

124

114M

73.5K

46.4K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $180M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.